<DOC>
	<DOCNO>NCT01441245</DOCNO>
	<brief_summary>Intravenous loop diuretic therapy commonly use treat pulmonary congestion systemic fluid overload . In theory , continuous infusion allow consistent diuresis , avoid sodium reabsorption distal tubule well neurohormonal activation . This lead renal function improvement BNP decrease .</brief_summary>
	<brief_title>Loop Diuretics Administration Acute Heart Failure</brief_title>
	<detailed_description>Patients eligible admitted primary diagnosis ADHF , randomize within 12 h hospital presentation , evidence volume overload ( pulmonary congestion ) chest X-ray study BNP level &gt; 100 pg/ml . Patients also display mild moderate renal dysfunction creatinine value 1.4 mg/dl . Some patient support non invasive ventilation randomization . Once initial 12 h dose determine , patient randomize use 1:1 ratio use computer-generated scheme receive furosemide dose either divide twice-daily bolus injection continuous infusion ( mixed 1:1 ratio 5 % dextrose water ) time period range 72 120 h. The randomization casual , physicians previously know assign arm . The dose escalation subsequent titration furosemide guide clinical response term urine output volume body weight reduction .Before randomization , renal function parameter BNP level measure patient . Subsequent titration furosemide dosage discretion attend physician , guide dose-escalation algorithm base treatment response ( weight loss urine output volume ) , symptom improvement , change renal function , electrolyte balance , chest radiography . The specific dos furosemide use additional agent manage ADHF ( dopamine , IV vasodilator , hypertonic saline infusion ) decide base upon blood pressure measurement , renal function evaluation diuresis response . Supplementary treatment leave discretion treat physician . The duration infusion continue 72 h , 48 h physician possibility adjust diuretic dose administration basis clinical response . After 72 h treatment could stop continue additional 36-48 h depend patient 's condition diuresis response . Acute kidney injury ( AKI ) define follow RIFLE criterion . Abbreviations : ( AKI ) Acute kidney injury ( ADHF ) Acute decompensated heart failure ( BNP ) B-type natriuretic peptide ( CHD ) Coronary heart disease ( cIV ) Continuous infusion ( iIV ) Intermittent infusione ( eGFR ) Estimated glomerular filtration rate ( Hb ) Hemoglobin ( HF ) Heart failure ( Hct ) Hematocrit ( LVEF ) Left ventricular ejection fraction ( RBC ) Red blood cell</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>Patients take part random sample selection meet diagnostic criterion acute decompensated HF . They also display impaired ejection fraction ( LVEF &lt; 45 % ) cardiac dilatation pulmonary hypertension Patients exclude receive 2 IV dos furosemide continuous infusion furosemide 1 month randomization If endstage renal disease need renal replacement therapy , isolate diastolic dysfunction Recent myocardial infarction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>acute heart failure</keyword>
	<keyword>diuretic</keyword>
	<keyword>BNP</keyword>
	<keyword>Renal function</keyword>
	<keyword>acute decompensated Heart Failure ,</keyword>
	<keyword>volume overload</keyword>
</DOC>